Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects

Clinical trial NCT05363293 · COMPLETED

Trial details

NCT number: NCT05363293
Sponsor: Alzamend Neuro, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease Healthy Non-elderly and Elderly Adults

Start date: 2022-05-04
Primary completion: 2023-04-14
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.